abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Total Costs & Expenses
-$17.27M
Quarterly · Period ending: · USD
HQL Total Costs & Expenses
Latest reported-$17.27Mperiod ending
Latest reported-$17.27Mperiod ending
HQL Quarterly Total Costs & Expenses ($945.00K → -$17.27M)
Quarterly Total Costs & Expenses
High-resolution chart · PNG
HQL total costs & expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| -17,270,049 | |
| -121,194,984 | |
| 65,432,976 | |
| 3,181,733 | |
| 2,718,600 | |
| 41,011,842 | |
| 2,870,019 | |
| 49,997,808 | |
| 86,470,106 | |
| -16,991,934 | |
| -2,522,493 | |
| -76,374,958 | |
| -7,617,571 | |
| 2,631,170 | |
| 2,688,454 | |
| 2,815,402 | |
| 2,777,532 | |
| 40,874 | |
| 25,998 | |
| 56,658 | |
| 70,006 | |
| 51,390 | |
| 90,566 | |
| 53,368 | |
| 35,020 | |
| 58,400 | |
| 12,863 | |
| 21,713,430 | |
| 53,772,167 | |
| 2,185,000 | |
| 2,185,000 | |
| 1,890,000 | |
| 1,890,000 | |
| 1,805,000 | |
| 1,805,000 | |
| 2,290,000 | |
| 2,290,000 | |
| 2,295,000 | |
| 2,295,000 | |
| 1,820,000 | |
| 1,820,000 | |
| 1,735,000 | |
| 1,735,000 | |
| 1,695,000 | |
| 1,695,000 | |
| 1,475,000 | |
| 1,475,000 | |
| 1,725,000 | |
| 1,725,000 | |
| 1,855,000 | |
| 1,855,000 | |
| 940,000 | |
| 940,000 | |
| 930,000 | |
| 930,000 | |
| 945,000 | |
| 945,000 |